Company

EQL Pharma AB

Headquarters: Lund, Sweden

Employees: 11

CEO: Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.

FSX: 7JK +1.72%

Market Cap

€205.7 Million

EUR as of Jan. 1, 2025

US$214.1 Million

Market Cap History

EQL Pharma AB Categories

Sweden Healthcare Drug Manufacturers—Specialty & Generic
Sweden Healthcare Sweden Drug Manufacturers—Specialty & Generic

EQL Pharma AB market capitalization over time

Evolution of EQL Pharma AB market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of EQL Pharma AB

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

EQL Pharma AB (publ) engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. The company was incorporated in 2006 and is based in Lund, Sweden.

Stocks & Indices

EQL Pharma AB has the following listings and related stock indices.


Stock: FSX: 7JK wb_incandescent

Details

Headquarters:

Stortorget 1

3rd Floor

Lund, 222 23

Sweden

Phone: 46 46 12 01 70

Fax: 46 46 12 00 12